SC
SCL Science Inc.
246960 | KO
Overview
Corporate Details
- ISIN(s):
- KR7246960009
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 영등포구 선유로13길 25 에이스하이테크시티 2차 1209호, 서울특별시
- Website:
- https://sclscience.com/en
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
M&A Activity
타법인주식및출자증권취득결정(자율공시)
|
Korean | 16.2 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-08-14 00:00 |
Regulatory Filings
단일판매ㆍ공급계약체결
|
Korean | 10.4 KB | ||
| 2025-08-14 00:00 |
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 13.7 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-08-11 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 114.2 KB | ||
| 2025-07-28 00:00 |
Delisting Announcement
주권매매거래정지 (영업양수도)
|
Korean | 4.8 KB | ||
| 2025-07-28 00:00 |
M&A Activity
주요사항보고서(영업양수결정)
|
Korean | 18.8 KB | ||
| 2025-07-21 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(무상증자결정)
|
Korean | 15.0 KB |
Automate Your Workflow. Get a real-time feed of all SCL Science Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for SCL Science Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SCL Science Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden
ELIC
Sweden
ELIC
Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.
United States of America
ELTX
United States of America
ELTX
A deep-tech factory building Physical AI ventures for mobility, logistics, and automation.
Italy
E9IA
Italy
E9IA
Developing safer opioids with abuse-deterrent and overdose protection technology for severe pain.
United States of America
ENSC
United States of America
ENSC
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
United States of America
ENVB
United States of America
ENVB
Provides NGS-based genetic analysis for disease prevention and personalized healthcare.
South Korea
245620
South Korea
245620
South Korea
446440
Clinical-stage biotech creating therapies for severe autoimmune and inflammatory disorders.
United States of America
EQ
United States of America
EQ
CRO offering preclinical drug profiling, screening & pharmacology testing for pharma/biotech.
France
ALECR
France
ALECR
Develops AI-powered, personalized vaccines for cancer and infectious diseases.
United States of America
EVAX
United States of America
EVAX